Reference : Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Cr...
Scientific journals : Other
Human health sciences : Gastroenterology & hepatology
http://hdl.handle.net/2268/144438
Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Crohn’s Disease
English
De Greef, E [> >]
Hoffman, I [> >]
D'haens, G [> >]
Van Biervliet, S [> >]
Smets, F [> >]
Scaillon, M [> >]
De Wit, O [> >]
Peeters, H [> >]
Paquot, I [> >]
Alliet, P [> >]
Arts, W [> >]
Hauser, B [> >]
Vermeire, S [> >]
Van Gossum, A [> >]
Rahier, J F [> >]
Etienne, I [> >]
Louis, Edouard mailto [Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie >]
Coche, J C [> >]
Mahachie John, Jestinah mailto [Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique >]
Van Steen, Kristel mailto [Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique >]
Veereman, G [> >]
2012
Journal of Crohn’s and Colitis
Yes
http://hdl.handle.net/2268/144438

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn.docPublisher postprint29.5 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.